no ethics approval cuz we r completing preclinical studies atm in vivo n in vitro as per the presoethics comes next then recruit then starti expect gingivitis to have ethics next month hopefully
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%